- Home
- LH vs DGX Comparison
LH vs DGX Comparison
Compare LH & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LH
- DGX
- Stock Information
- Founded
- LH 1971
- DGX 1967
- Country
- LH United States
- DGX United States
- Employees
- LH N/A
- DGX N/A
- Industry
- LH Medical Specialities
- DGX Medical Specialities
- Sector
- LH Health Care
- DGX Health Care
- Exchange
- LH Nasdaq
- DGX Nasdaq
- Market Cap
- LH 19.7B
- DGX 17.5B
- IPO Year
- LH N/A
- DGX 1996
- Fundamental
- Price
- LH $235.28
- DGX $160.46
- Analyst Decision
- LH Buy
- DGX Buy
- Analyst Count
- LH 16
- DGX 13
- Target Price
- LH $256.14
- DGX $163.38
- AVG Volume (30 Days)
- LH 831.8K
- DGX 1.0M
- Earning Date
- LH 10-24-2024
- DGX 10-22-2024
- Dividend Yield
- LH 1.22%
- DGX 1.87%
- EPS Growth
- LH N/A
- DGX 11.56
- EPS
- LH 5.14
- DGX 7.44
- Revenue
- LH $12,712,800,000.00
- DGX $9,539,000,000.00
- Revenue This Year
- LH $10.03
- DGX $7.33
- Revenue Next Year
- LH $6.26
- DGX $8.69
- P/E Ratio
- LH $45.80
- DGX $21.57
- Revenue Growth
- LH 5.43
- DGX 2.60
- 52 Week Low
- LH $191.97
- DGX $123.04
- 52 Week High
- LH $247.99
- DGX $162.59
- Technical
- Relative Strength Index (RSI)
- LH 56.20
- DGX 60.76
- Support Level
- LH $224.64
- DGX $156.10
- Resistance Level
- LH $247.18
- DGX $162.59
- Average True Range (ATR)
- LH 5.18
- DGX 2.91
- MACD
- LH 0.63
- DGX 0.37
- Stochastic Oscillator
- LH 45.57
- DGX 79.72
About LH Laboratory Corporation of America Holdings
Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
About DGX Quest Diagnostics Incorporated
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.